루이체 치매(LBD) 시장 규모는 향후 몇 년 동안 큰 폭의 성장을 보일 것으로 예상됩니다. 2029년에는 7.2%의 연평균 성장률(CAGR)로 16억 6천만 달러까지 성장할 것으로 예상됩니다. 예측 기간 동안 치매 유병률 증가, 연구 개발에 대한 투자 확대, 조기 진단에 대한 수요 증가, 원격 의료 도입 확대, 개인 맞춤형 의료에 대한 관심 증가가 성장을 주도할 것으로 예상됩니다. 예상되는 주요 트렌드로는 표적 치료법 개발, 임상시험 확대, 진단 기술의 발전, 기술 혁신, 새로운 치료법에 대한 강조 등이 있습니다.
뇌 관련 장애의 유병률 증가는 루이체 치매 시장의 성장을 견인할 것으로 예상됩니다. 뇌 관련 장애는 뇌의 구조와 기능에 영향을 미쳐 인지력 저하, 기억력 감퇴, 행동 변화로 이어지는 다양한 질환을 포괄합니다. 이러한 장애의 발생 증가는 노화, 유전적 소인, 환경적 영향 등의 요인에 기인합니다. 뇌 관련 질환이 보편화됨에 따라 루이체 치매에 대한 치료법 개선과 조기 발견에 대한 수요도 증가하고 있습니다. 이러한 수요 증가는 연구, 자금 지원, 혁신을 가속화하여 루이체 치매 진단과 치료의 빠른 발전으로 이어지고 있습니다. 예를 들어, 2023년 10월 영국에 본부를 둔 국가 신경 학회 연합인 세계 신경학 연맹은 전 세계 인구의 40% 이상이 신경 질환의 영향을 받고 있으며, 2050년까지 이러한 부담이 거의 두 배로 증가할 것으로 예상한다고 보고했습니다. 따라서 뇌 관련 질환의 유병률 증가는 루이체 치매 시장의 확대에 기여할 것으로 예상됩니다.
루이체 치매 시장을 선도하는 기업들은 신경 퇴행성 질환에 대한 보다 효과적인 치료법을 개발하기 위해 연구 투자에 우선순위를 두고 있습니다. 연구 투자에는 새로운 통찰력을 얻고 혁신적인 솔루션을 개발하며 기존 치료법을 개선하기 위한 과학 및 기술 연구에 재정 자원, 시간, 노력을 할당하는 것이 포함됩니다. 이러한 투자는 질병 탐색과 신약 개발을 지원하여 궁극적으로 환자 치료 결과를 개선합니다. 예를 들어, 2023년 3월 미국 정부 기관인 국립노화연구소는 루이체 치매(LBD) 신약 개발 연구를 위해 2,100만 달러를 지원했습니다. 마이애미 대학교 밀러 의과대학의 연구원들은 유망한 초기 결과에 따라 네플라마피모드에 대한 2b상 연구를 시작했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 루이체 치매 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 루이체 치매 시장 : 성장률 분석
- 세계의 루이체 치매 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 루이체 치매 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 루이체 치매 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 루이체 치매 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 임상 진단
- 바이오마커 진단
- 세계의 루이체 치매 시장 : 약물별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 콜린에스테라아제 억제제
- 항정신병약
- 항우울제
- 기타 약물
- 세계의 루이체 치매 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 전문 클리닉
- 장기 요양 시설
- 기타 최종 사용자
- 세계의 루이체 치매 시장 : 임상 진단 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 신경심리학적 검사
- 신경학적 검사
- 병력 검토
- 인지기능 평가
- 세계의 루이체 치매 시장 : 바이오마커 진단 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 뇌척수액(CSF) 바이오마커
- 이미지 바이오마커(PET, MRI)
- 유전자 바이오마커
- 혈액 기반 바이오마커
제7장 지역별 및 국가별 분석
- 세계의 루이체 치매 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 루이체 치매 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 루이체 치매 시장 : 경쟁 구도
- 루이체 치매 시장 : 기업 프로파일
- Eli Lilly and Company 개요, 제품 및 서비스, 전략 및 재무 분석
- Mayo Foundation for Medical Education and Research 개요, 제품 및 서비스, 전략 및 재무 분석
- Eisai Co. Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- Sumitomo Dainippon Pharma Co. Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- Georgetown University Medical Center 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Alzheimer's Society
- BioArctic AB
- Annovis Bio Inc.
- Sun Pharma Advanced Research Company Limited
- Voyager Therapeutics Inc.
- Cognition Therapeutics
- Athira Pharma
- Allergan plc
- Inhibikase Therapeutics
- CuraSen Therapeutics Inc.
- CervoMed Inc.
- AC Immune SA
- ProMIS Neurosciences Inc.
- Aptinyx Inc.
- EIP Pharma Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 루이체 치매 시장(2029년) : 새로운 기회를 제공하는 국가
- 루이체 치매 시장(2029년) : 새로운 기회를 제공하는 부문
- 루이체 치매 시장(2029년) : 성장 전략
제36장 부록
HBR
Lewy body dementia (LBD) is a neurodegenerative disorder caused by abnormal protein deposits in the brain, affecting cognition, movement, and behavior. This leads to a gradual decline in both mental and physical abilities, with symptoms such as memory loss, hallucinations, tremors, and motor impairments. Proper management is crucial to address the cognitive and physical challenges associated with the condition.
Primary diagnosis of Lewy body dementia is conducted through clinical and biomarker-based methods. Clinical diagnosis involves assessing medical history, symptoms, and physical examinations to facilitate early detection and treatment. Management of the condition includes medications such as cholinesterase inhibitors, antipsychotics, and antidepressants. Various healthcare settings, including hospitals, specialty clinics, and long-term care facilities, play a crucial role in providing treatment and support.
The lewy body dementia market research report is one of a series of new reports from The Business Research Company that provides lewy body dementia market statistics, including the lewy body dementia industry global market size, regional shares, competitors with the lewy body dementia market share, detailed lewy body dementia market segments, market trends, and opportunities, and any further data you may need to thrive in the lewy body dementia industry. This lewy body dementia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The lewy body dementia market size has grown strongly in recent years. It will grow from $1.12 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the rising aging population, increased awareness of neurodegenerative diseases, higher healthcare expenditures, improved diagnostic criteria, and regulatory approvals for dementia medications.
The lewy body dementia market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. In the forecast period, growth is expected to be driven by the increasing prevalence of dementia, greater investment in research and development, rising demand for early diagnosis, expanded adoption of telemedicine, and a growing focus on personalized medicine. Key trends anticipated include the development of targeted therapies, expansion of clinical trials, advancements in diagnostic techniques, technological innovations, and an emphasis on novel therapeutics.
The increasing prevalence of brain-related disorders is expected to drive the growth of the Lewy body dementia market. Brain-related disorders encompass a range of conditions that affect the brain's structure and function, leading to cognitive decline, memory loss, and behavioral changes. The rising occurrence of these disorders is attributed to factors such as aging, genetic predisposition, and environmental influences. As brain-related disorders become more common, the demand for improved treatments and early detection for Lewy body dementia is also rising. This increased demand accelerates research, funding, and innovation, leading to faster advancements in diagnosis and therapy for the condition. For instance, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that over 40% of the global population is affected by neurological conditions, with this burden projected to nearly double by 2050. Therefore, the rising prevalence of brain-related disorders is expected to contribute to the expansion of the Lewy body dementia market.
Leading companies in the Lewy body dementia market are prioritizing research investments to develop more effective treatments for neurodegenerative diseases. Research investment involves allocating financial resources, time, and effort to scientific and technological studies aimed at gaining new insights, developing innovative solutions, and enhancing existing treatments. Such investments support disease exploration and the development of new medications, ultimately improving patient outcomes. For example, in March 2023, the National Institute on Aging, a US-based government agency, awarded $21 million to fund drug development research for Lewy body dementia (LBD). Researchers at the University of Miami Miller School of Medicine have launched a Phase 2b study of neflamapimod following promising early results.
In March 2023, CND Life Sciences, a US-based developer of highly accurate skin-based tests for diagnosing dementia with Lewy bodies, partnered with Beth Israel Deaconess Medical Center (BIDMC) to enhance its diagnostic tool for neurodegenerative diseases. This collaboration aims to leverage advanced technology to improve the detection of misfolded alpha-synuclein proteins and explore additional protein markers linked to other neurodegenerative conditions. The goal is to facilitate more accurate diagnoses and enhance patient outcomes as new therapies become available. Beth Israel Deaconess Medical Center (BIDMC) is a US-based institution specializing in diagnosing and treating conditions such as Lewy body disease.
Major players in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., and EIP Pharma Inc.
North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lewy body dementia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the lewy body dementia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lewy body dementia market consists of revenues earned by entities by providing services such as cognitive and motor function therapies, pharmaceutical treatments, and physical therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lewy body dementia market also includes sales of sleep aids, mood stabilizers, and anxiolytics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lewy Body Dementia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lewy body dementia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lewy body dementia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lewy body dementia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Diagnosis: Clinical Diagnosis; Biomarker-Based Diagnosis
- 2) By Medication: Cholinesterase Inhibitors; Antipsychotics; Antidepressants; Other Medications
- 3) By End-User: Hospitals; Specialty Clinics; Long-Term Care Facilities; Other End-Users
- Subsegments:
- 1) By Clinical Diagnosis: Neuropsychological Testing; Neurological Examination; Medical History Review; Cognitive Function Assessment
- 2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers; Imaging Biomarkers (PET, MRI); Genetic Biomarkers; Blood-Based Biomarkers
- Companies Mentioned: Eli Lilly and Company; Mayo Foundation for Medical Education and Research; Eisai Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Georgetown University Medical Center
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lewy Body Dementia Market Characteristics
3. Lewy Body Dementia Market Trends And Strategies
4. Lewy Body Dementia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Lewy Body Dementia Growth Analysis And Strategic Analysis Framework
- 5.1. Global Lewy Body Dementia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Lewy Body Dementia Market Growth Rate Analysis
- 5.4. Global Lewy Body Dementia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Lewy Body Dementia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Lewy Body Dementia Total Addressable Market (TAM)
6. Lewy Body Dementia Market Segmentation
- 6.1. Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Clinical Diagnosis
- Biomarker-Based Diagnosis
- 6.2. Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cholinesterase Inhibitors
- Antipsychotics
- Antidepressants
- Other Medications
- 6.3. Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Long-Term Care Facilities
- Other End-Users
- 6.4. Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neuropsychological Testing
- Neurological Examination
- Medical History Review
- Cognitive Function Assessment
- 6.5. Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cerebrospinal Fluid (CSF) Biomarkers
- Imaging Biomarkers (PET, MRI)
- Genetic Biomarkers
- Blood-Based Biomarkers
7. Lewy Body Dementia Market Regional And Country Analysis
- 7.1. Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lewy Body Dementia Market
- 8.1. Asia-Pacific Lewy Body Dementia Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lewy Body Dementia Market
- 9.1. China Lewy Body Dementia Market Overview
- 9.2. China Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lewy Body Dementia Market
- 10.1. India Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lewy Body Dementia Market
- 11.1. Japan Lewy Body Dementia Market Overview
- 11.2. Japan Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lewy Body Dementia Market
- 12.1. Australia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lewy Body Dementia Market
- 13.1. Indonesia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lewy Body Dementia Market
- 14.1. South Korea Lewy Body Dementia Market Overview
- 14.2. South Korea Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lewy Body Dementia Market
- 15.1. Western Europe Lewy Body Dementia Market Overview
- 15.2. Western Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lewy Body Dementia Market
- 16.1. UK Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lewy Body Dementia Market
- 17.1. Germany Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lewy Body Dementia Market
- 18.1. France Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lewy Body Dementia Market
- 19.1. Italy Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lewy Body Dementia Market
- 20.1. Spain Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lewy Body Dementia Market
- 21.1. Eastern Europe Lewy Body Dementia Market Overview
- 21.2. Eastern Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lewy Body Dementia Market
- 22.1. Russia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lewy Body Dementia Market
- 23.1. North America Lewy Body Dementia Market Overview
- 23.2. North America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lewy Body Dementia Market
- 24.1. USA Lewy Body Dementia Market Overview
- 24.2. USA Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lewy Body Dementia Market
- 25.1. Canada Lewy Body Dementia Market Overview
- 25.2. Canada Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lewy Body Dementia Market
- 26.1. South America Lewy Body Dementia Market Overview
- 26.2. South America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lewy Body Dementia Market
- 27.1. Brazil Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lewy Body Dementia Market
- 28.1. Middle East Lewy Body Dementia Market Overview
- 28.2. Middle East Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lewy Body Dementia Market
- 29.1. Africa Lewy Body Dementia Market Overview
- 29.2. Africa Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lewy Body Dementia Market Competitive Landscape And Company Profiles
- 30.1. Lewy Body Dementia Market Competitive Landscape
- 30.2. Lewy Body Dementia Market Company Profiles
- 30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Georgetown University Medical Center Overview, Products and Services, Strategy and Financial Analysis
31. Lewy Body Dementia Market Other Major And Innovative Companies
- 31.1. Alzheimer's Society
- 31.2. BioArctic AB
- 31.3. Annovis Bio Inc.
- 31.4. Sun Pharma Advanced Research Company Limited
- 31.5. Voyager Therapeutics Inc.
- 31.6. Cognition Therapeutics
- 31.7. Athira Pharma
- 31.8. Allergan plc
- 31.9. Inhibikase Therapeutics
- 31.10. CuraSen Therapeutics Inc.
- 31.11. CervoMed Inc.
- 31.12. AC Immune SA
- 31.13. ProMIS Neurosciences Inc.
- 31.14. Aptinyx Inc.
- 31.15. EIP Pharma Inc.
32. Global Lewy Body Dementia Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lewy Body Dementia Market
34. Recent Developments In The Lewy Body Dementia Market
35. Lewy Body Dementia Market High Potential Countries, Segments and Strategies
- 35.1 Lewy Body Dementia Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Lewy Body Dementia Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Lewy Body Dementia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
